NASDAQ: NRC
Nrc Health Stock Forecast, Predictions & Price Target

Analyst price target for NRC

Based on 1 analyst offering 12 month price targets for Nrc Health

Min Forecast
$26.00+33.26%
Avg Forecast
$26.00+33.26%
Max Forecast
$26.00+33.26%

Should I buy or sell NRC stock?

Based on 1 analyst offering ratings for Nrc Health.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their NRC stock forecasts and price targets.

NRC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-07-29

1 of 1

Forecast return on equity

Is NRC forecast to generate an efficient return?

Company
180.48%
Industry
14.51%
Market
140.1%
NRC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NRC forecast to generate an efficient return on assets?

Company
18.1%
Industry
10.85%
NRC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NRC earnings per share forecast

What is NRC's earnings per share in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
$0.82+115.29%
Avg 2 year Forecast
$1.08+184.39%
NRC's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

NRC revenue forecast

What is NRC's revenue in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
$144.0M+3.89%
Avg 2 year Forecast
$156.1M+12.56%
NRC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NRC earnings growth forecast

How is NRC forecast to perform vs Health Information Services companies and vs the US market?

Company
115.29%
Industry
76.53%
Market
1,393.92%
NRC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
NRC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
NRC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

NRC revenue growth forecast

How is NRC forecast to perform vs Health Information Services companies and vs the US market?

Company
3.89%
Industry
10.73%
Market
21.82%
NRC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NRC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NRC vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
NRC$19.51$26.00+33.26%Buy
SOPH$5.67$10.00+76.37%Strong Buy
CTEV$22.71$29.20+28.58%Strong Buy
SLP$18.23$16.00-12.23%Hold
WEAV$6.54$8.50+29.97%Strong Buy

Nrc Health Stock Forecast FAQ

Is Nrc Health Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: NRC) stock is to Buy NRC stock.

Out of 1 analyst, 0 (0%) are recommending NRC as a Strong Buy, 1 (100%) are recommending NRC as a Buy, 0 (0%) are recommending NRC as a Hold, 0 (0%) are recommending NRC as a Sell, and 0 (0%) are recommending NRC as a Strong Sell.

If you're new to stock investing, here's how to buy Nrc Health stock.

What is NRC's earnings growth forecast for 2026-2027?

(NASDAQ: NRC) Nrc Health's forecast annual earnings growth rate of 115.29% is forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 76.53%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,393.92%.

Nrc Health's earnings in 2026 is $9,036,000.On average, 2 Wall Street analysts forecast NRC's earnings for 2026 to be $18,437,271, with the lowest NRC earnings forecast at $17,889,629, and the highest NRC earnings forecast at $19,167,460.

In 2027, NRC is forecast to generate $24,355,407 in earnings, with the lowest earnings forecast at $23,631,979 and the highest earnings forecast at $25,319,978.

What is NRC's revenue growth forecast for 2026-2027?

(NASDAQ: NRC) Nrc Health's forecast annual revenue growth rate of 3.89% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 10.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 21.82%.

Nrc Health's revenue in 2026 is $138,643,000.On average, 2 Wall Street analysts forecast NRC's revenue for 2026 to be $3,245,960,325, with the lowest NRC revenue forecast at $3,149,503,266, and the highest NRC revenue forecast at $3,374,419,492.

In 2027, NRC is forecast to generate $3,516,851,411 in revenue, with the lowest revenue forecast at $3,412,281,141 and the highest revenue forecast at $3,656,128,192.

What is NRC's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: NRC) forecast ROA is 18.1%, which is higher than the forecast US Health Information Services industry average of 10.85%.

What is NRC's Price Target?

According to 1 Wall Street analyst that have issued a 1 year NRC price target, the average NRC price target is $26.00, with the highest NRC stock price forecast at $26.00 and the lowest NRC stock price forecast at $26.00.

The Wall Street analyst predicted that Nrc Health's share price could reach $26.00 by Jul 29, 2027. The average Nrc Health stock price prediction forecasts a potential upside of 33.26% from the current NRC share price of $19.51.

What is NRC's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: NRC) Nrc Health's current Earnings Per Share (EPS) is $0.38. On average, analysts forecast that NRC's EPS will be $0.82 for 2026, with the lowest EPS forecast at $0.79, and the highest EPS forecast at $0.85. In 2027, NRC's EPS is forecast to hit $1.08 (min: $1.05, max: $1.12).

What is NRC's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: NRC) forecast ROE is 180.48%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.